| First Author | Imhoff FM | Year | 2013 |
| Journal | FEBS Lett | Volume | 587 |
| Issue | 12 | Pages | 1749-53 |
| PubMed ID | 23624077 | Mgi Jnum | J:198823 |
| Mgi Id | MGI:5499265 | Doi | 10.1016/j.febslet.2013.04.014 |
| Citation | Imhoff FM, et al. (2013) The type 2 anti-Mullerian hormone receptor has splice variants that are dominant-negative inhibitors. FEBS Lett 587(12):1749-53 |
| abstractText | Anti-Mullerian hormone (AMH) has both paracrine and hormonal actions that occur at different AMH concentrations, and in cells with different densities of its specific receptor (Amhr2). This diversity is not explained by canonical AMH signaling. We report that Amhr2 has two splice variants: Amhr2Delta2 (AMH binding site) and Amhr2Delta9/10 (kinase domain). Both spliced variants inhibit AMH signaling in a reporter assay. The mRNA for the spliced variants was relatively less abundant than Amhr2 mRNA in all tissues. This suggests that the physiological function(s) of the receptor variants may be restricted to specific cellular/subcellular sites and/or to the transport of AMH. |
